Video Experimental Relacionado
Updated: Jul 25, 2026
09:41
Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery
Published on: December 23, 2014
Plaquetas, vasoconstricción y nitroglicerina durante la lesión de la pared arterial. Un nuevo papel antitrombótico
J Y Lam1, J H Chesebro, V Fuster
1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905.
Circulation
|September 1, 1988
Resumen
La nitroglicerina reduce efectivamente la deposición de plaquetas y la vasoconstricción después de una lesión arterial profunda en cerdos. Este estudio demuestra su eficacia in vivo para mitigar estas respuestas después de la angioplastia con globo.
Área de la Ciencia:
- Biología vascular Biología vascular
- Farmacología Farmacología.
- Investigaciones cardiovasculares en la investigación cardiovascular.
Sus antecedentes:
- La lesión endotelial desencadena la deposición de plaquetas y la vasoconstricción.
- Los efectos de la nitroglicerina en estas respuestas no se comprenden completamente in vivo.
- La angioplastia con globo puede causar diversos grados de lesión arterial.
Objetivo del estudio:
- Para investigar el impacto de la nitroglicerina en la deposición de plaquetas y la vasoconstricción después de una lesión arterial.
- Para diferenciar los efectos de la nitroglicerina en lesiones arteriales leves versus profundas.
- Evaluar el papel de la nitroglicerina en la prevención de las complicaciones posteriores a la angioplastia.
Principales métodos:
- Se utilizaron plaquetas etiquetadas con 111In para cuantificar la deposición en las arterias carótidas porcinas lesionadas.
- Evaluación de la vasoconstricción mediante el estrechamiento del diámetro angiográfico.
- Se administró nitroglicerina intravenosa y se compararon los resultados con los grupos de control.
Principales resultados:
- La lesión arterial profunda condujo a una deposición de plaquetas y vasoconstricción significativamente más altas que la lesión leve.
- La nitroglicerina redujo significativamente tanto la deposición de plaquetas como la vasoconstricción en lesiones profundas.
- En lesiones leves, la nitroglicerina redujo principalmente la vasoconstricción, lo que sugiere un efecto relajante directo del músculo liso.
Conclusiones:
- La nitroglicerina demuestra efectividad in vivo en la reducción de la deposición de plaquetas después de una lesión arterial profunda.
- El fármaco también mitiga las respuestas vasoconstrictivas, particularmente en lesiones profundas.
- Los hallazgos sugieren que la nitroglicerina tiene propiedades antiplaquetarias y relajantes del músculo liso relevantes para la lesión vascular.
Videos de Conceptos Relacionados
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...